Literature DB >> 1092799

Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

H Cantor, E A Boyse.   

Abstract

Lymphocytes from BALB/c or C57B6/6 mice that develop killer activity to alloantigens belong to the numerically small Ly-23 subclass of peripheral T cells, distinguished by selective expression of Ly-23 determinants on their surfaces. The maturation of these cells to killer cells can be amplified by Ly-1+ cells, which do not themselves contribute to the killer cell pool. This amplification was abolished by escluding Ia("Beta")+ cells from the stimulator population during mixed lymphocyte culture (MCL), suggesting that amplification is due to selective recognition of I region antigens by L-1+ cells, a conclusion already drawn from our previous evidence that Ia differences activate Ly-1+ cells but not Ly-23+ cells. These and other experiments indicate that amplification of killer cell production in vitro by Ly-1+ cells is not due to their conversion to Ly-23+ cells during MLC, but to their ability to recognize major histocompatibility complex determinants not recognized by Ly-23+ cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092799      PMCID: PMC2189854          DOI: 10.1084/jem.141.6.1390

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.

Authors:  V P Eijsvoogel; M J du Bois; A Meinesz; A Bierhorst-Eijlander; W P Zeylemaker; P T Schellekens
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

2.  An antigenic determinant of cytotoxic lymphocytes.

Authors:  K A Sullivan; G Berke; D B Amos
Journal:  Transplantation       Date:  1973-10       Impact factor: 4.939

3.  Synergism between subpopulations of thymus-derived cells mediating the proliferative and effector phases of the mixed lymphocyte reaction.

Authors:  L Cohen; M L Howe
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

4.  Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.

Authors:  R E Tigelaar; M Feldmann
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment.

Authors:  D J Schendel; B J Alter; F H Bach
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

6.  A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex.

Authors:  D H Sachs; J L Cone
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

7.  Synergy among lymphoid cells mediating the graft-versus-host response. II. Synergy in graft-versus-host reactions produced by Balb-c lymphoid cells of differing anatomic origin.

Authors:  H Cantor; R Asofsky
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

8.  Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells.

Authors:  H Cantor; R Asofsky
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

9.  Synergy during in vitro cytotoxic allograft responses. I. Evidence for cell interaction between thymocytes and peripheral T cells.

Authors:  H Wagner
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes.

Authors:  B J Alter; F H Bach
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  215 in total

1.  Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.

Authors:  H Fujiwara; T Hamaoka; K Teshima; H Aoki; M Kitagawa
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

2.  The differentiation of cytotoxic T lymphocytes in vitro: an ultrastructural study.

Authors:  A Matter; E Simpson
Journal:  Cell Tissue Res       Date:  1976-02-27       Impact factor: 5.249

3.  Regeneration of autotransplanted splenic tissue at different implantation sites.

Authors:  A Liaunigg; C Kastberger; W Leitner; M E Kurz; E S Bergmann; M Seifriedsberger; D Weinlich; W Pimpl; J Thalhamer
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

4.  Help and suppression by lymphoid cells as a function of cellular concentration.

Authors:  J Farrant; S C Knight
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

5.  Antigenic properties of lymph-node cells responding to allogeneic lymphocytes and to various concentrations of lectins.

Authors:  R Rabinowitz; R Laskov; M Schlesinger
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

6.  Interactions between lymphocytes and hematopoietic progenitor cells in normal and leukemic human bone marrow (phase contrast observations).

Authors:  I Boll
Journal:  Blut       Date:  1985-06

7.  Regulatory T cells in renal disease.

Authors:  Yuan Min Wang; Min Hu; Ya Wang; Tania Polhill; Geoff Yu Zhang; Yiping Wang; Vincent W S Lee; David C H Harris; Stephen I Alexander
Journal:  Int J Clin Exp Med       Date:  2008-08-20

8.  Developmental interrelationship of specific Lyt 123 and Lyt 1 cell sets in expression of antibacterial immunity to Listeria monocytogenes.

Authors:  H Näher; U Sperling; H Hahn
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 9.  Viewing transplantation immunology through today's lens: new models, new imaging, and new insights.

Authors:  Alex Y Huang; W Nicholas Haining; Deborah S Barkauskas; Jay T Myers; Agne Petrosiute; Aneesah P Garrett; Karnail Singh; Kenneth R Cooke; Leslie S Kean
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-22       Impact factor: 5.742

Review 10.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.